Nasdaq: RNAC
Cartesian Therapeutics insiders
The officers, directors and 10% owners of Cartesian Therapeutics, Inc. who hold the most stock, valued at the live RNAC price.
$5.89
RNAC today −$410K (−6.51%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 6
- Their RNAC stock
- $114M
- Market value
- $189M
- Held by ranked insiders
- 60.7%
Insiders by value of RNAC holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Timothy A. Springer | Director | 8,976,980 | $52.9M | 28.0% | 1111th |
| 2 | Murat Kalayoglu | 10% owner | 7,718,890 | $45.5M | 24.1% | 2716th |
| 3 | Elizabeth Hoge | 10% owner | 2,656,631 | $15.6M | 8.30% | 6212th |
| 4 | Timothy C. Barabe | Director | 56,966 | $336K | 0.18% | 9717th |
| 5 | Carrie Smith Cox | Director | 15,629 | $92K | <0.1% | 4398th |
| 6 | Patrick Zenner | Director | 12,974 | $76K | <0.1% | 6132nd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Cartesian Therapeutics; see each profile for the filing.